DOCSLIB.ORG

Downloaded on 20 February 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Downloaded on 20 February 2014 GENOME-WIDE APPROACHES TO INVESTIGATE RARE NEUROLOGICAL DISORDERS IN FRENCH CANADIANS Karine Choquet Department of Human Genetics McGill University, Montréal, Canada April 2018 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Doctor of Philosophy © Karine Choquet, 2018 ABSTRACT The French Canadian population of Québec is defined by a unique history and genetic heritage, which has led to the regional clustering of a large number of Mendelian diseases. This includes several types of cerebellar ataxias, a heterogeneous group of neurological disorders characterized by impaired balance and coordination. In the past 20 years, the causative genes have been identified for the major forms of autosomal recessive cerebellar ataxias (ARCA) in Québec. However, approximately 30% of French Canadian ARCA patients remain without a definite molecular diagnosis. We combined whole exome and targeted sequencing and identified the underlying genetic defect in 13 families, representing more than 40% of our unresolved ARCA cohort. Specifically, we uncovered pathogenic SPG7 mutations in 12 families, demonstrating that this is an important cause of spastic ataxia in Québec. In the last family, we found a homozygous mutation in the gene PMPCA, a recently described novel cause of ARCA. In order to improve the number of available treatments for cerebellar ataxias, it is crucial to gain a better understanding of the pathogenic mechanisms responsible for these diseases. Thus, we next focused on one specific ataxia-related disorder, Pol III-related hypomyelinating leukodystrophy (POLR3-HLD), and on unraveling its pathophysiological processes. POLR3- HLD is characterized by deficient cerebral myelin formation and is caused by recessive mutations in the genes POLR3A, POLR3B and POLR1C, encoding three subunits of RNA Polymerase III (Pol III). Pol III is an essential enzyme responsible for the synthesis of transfer RNAs (tRNA) and many small non-coding RNAs. First, we generated two knock-in mouse models and performed an in-depth phenotypic and molecular characterization. We found that the Polr3a c.2015G>A (p.G672E) mutation does not lead to a neurological phenotype in mouse, contrary to what is observed in human homozygotes, and that the G672E mutation causes only a mild defect in Pol III function in human cells. Next, using CRISPR-Cas9 gene editing and two complementary RNA-sequencing approaches, we observed that mutations in POLR3A lead to decreased expression of a subset of Pol III transcripts in human cell lines, with the most potent impact on nuclear-encoded tRNAs, the signal recognition particle 7SL RNA and the brain cytoplasmic BC200 RNA. Furthermore, expression profiling in patient-derived fibroblasts and genomic deletion of BC200 in an oligodendroglial cell line provide the first evidence linking this non-coding RNA to POLR3-HLD pathogenesis. Overall, our findings contribute to a better understanding of the genetic and molecular basis of three distinct ataxia-related disorders in 2 French Canadians, while providing insights into the role of an essential enzyme in mouse and human. 3 RÉSUMÉ La population canadienne française du Québec est caractérisée par une histoire et un héritage génétique uniques ayant mené au regroupement régional de nombreuses maladies héréditaires. Celles-ci incluent diverses formes d’ataxies cérébelleuses, un groupe hétérogène de maladies neurologiques définies par un défaut d’équilibre et de coordination. Au cours des vingt dernières années, les gènes causant les formes majeures d’ataxies cérébelleuses autosomiques récessives (ACAR) au Québec ont été identifiés. Pourtant, environ 30% de patients canadiens français atteints d’ACAR n’ont toujours pas de diagnostic moléculaire. En combinant des méthodes de séquençage exomique et ciblé, nous avons identifié le défaut génétique chez 13 familles, ce qui représente plus de 40% de notre cohorte de cas d’ACAR non résolus. Précisément, nous avons découvert des mutations pathogéniques dans le gène SPG7 chez 12 familles, démontrant ainsi qu’il s’agit d’une cause importante d’ataxie spastique au Québec. Chez la dernière famille, nous avons trouvé une mutation homozygote dans le gène PMPCA, une nouvelle cause d’ACAR récemment identifiée. Afin d’améliorer le nombre insuffisant de traitements disponibles pour les ataxies cérébelleuses, il est indispensable de mieux comprendre les mécanismes pathogéniques à l’origine de ces maladies. Ainsi, nous nous sommes ensuite concentrés sur la résolution des processus pathophysiologiques présents dans les leucodystrophies hypomyélinisantes reliées à l’ARN polymérase III (LDH-POLR3). Ce groupe de maladies caractérisé par un déficit de formation de la myéline dans le système nerveux central est aussi associé à la présence d’ataxie cérébelleuse et est causé par des mutations récessives dans les gènes POLR3A, POLR3B et POLR1C, codant pour trois sous-unités de l’ARN polymérase III (Pol III). Pol III est une enzyme essentielle qui synthétise les ARNs de transfert (ARNt) ainsi que de nombreux petits ARNs non codants. D’abord, nous avons généré deux modèles de souris et les avons caractérisés de façon détaillée aux niveaux phénotypique et moléculaire. Nos résultats montrent que la mutation c.2015G>A (p.G672E) dans Polr3a ne cause pas de phénotype neurologique chez la souris, contrairement à ce qui est observé chez les patients humains homozygotes. De plus, la mutation G672E n’entraîne qu’un défaut léger de la fonction de Pol III dans des cellules humaines. Ensuite, à l’aide de la technologie d’édition du génome CRISPR-Cas9 et de deux méthodes complémentaires de séquençage de l’ARN, nous avons découvert que des mutations dans POLR3A mènent à une diminution de l’expression d’un sous-groupe de transcrits Pol III dans des 4 lignées cellulaires humaines. Parmi les transcrits les plus affectés, nous retrouvons les ARNt, l’ARN 7SL de la particule de reconnaissance du signal et l’ARN cytoplasmique du cerveau BC200. De plus, à l’aide de mesures d’expression dans des fibroblastes de patients et de la délétion génomique de BC200 dans une lignée cellulaire oligodendrocytaire, nous démontrons un premier lien entre cet ARN non codant et la pathogénèse de la LDH-POLR3. En conclusion, nos données contribuent à une meilleure compréhension des bases génétiques et moléculaires de trois différentes maladies reliées à l’ataxie chez les Canadiens français, tout en approfondissant le rôle d’une enzyme essentielle chez la souris et l’humain. 5 Table of Contents ABSTRACT ................................................................................................................................... 2 RÉSUMÉ ........................................................................................................................................ 4 LIST OF ABBREVIATIONS ....................................................................................................... 9 LIST OF FIGURES ..................................................................................................................... 13 LIST OF TABLES ....................................................................................................................... 15 ACKNOWLEDGEMENTS ........................................................................................................ 16 PREFACE .................................................................................................................................... 18 Contribution of Authors ......................................................................................................... 19 Original Contribution to Knowledge ..................................................................................... 21 CHAPTER 1: General Introduction .......................................................................................... 22 1.1 Genetics of autosomal recessive cerebellar ataxias ........................................................ 23 1.1.1 Cerebellar ataxias ......................................................................................................... 23 1.1.2 Autosomal recessive cerebellar ataxias (ARCA) ......................................................... 24 1.1.3 ARCAs in the French Canadian population ................................................................. 24 1.1.4 Next-generation sequencing in the genetic diagnosis of ARCAs ................................ 26 1.2 Pol III-related leukodystrophies ...................................................................................... 28 1.2.1 Myelination in the central nervous system ................................................................... 28 1.2.2 Leukodystrophies ......................................................................................................... 30 1.2.3 Pol III-related leukodystrophy: a new disease entity ................................................... 32 1.2.4 Expansion of the phenotypic spectrum associated with POLR3A and POLR3B mutations ............................................................................................................................... 33 1.3 Function and regulation of RNA Polymerase III and its transcripts ........................... 35 1.3.1 Pol III transcription machinery and associated proteins ............................................... 35 1.3.2 Functions of Pol III transcripts ..................................................................................... 36 1.3.3 Regulation of Pol III transcription ...............................................................................
Load more

Recommended publications
  • PLATFORM ABSTRACTS Abstract Abstract Numbers Numbers Tuesday, November 6 41
    American Society of Human Genetics 62nd Annual Meeting November 6–10, 2012 San Francisco, California PLATFORM ABSTRACTS Abstract Abstract Numbers Numbers Tuesday, November 6 41. Genes Underlying Neurological Disease Room 134 #196–#204 2. 4:30–6:30pm: Plenary Abstract 42. Cancer Genetics III: Common Presentations Hall D #1–#6 Variants Ballroom 104 #205–#213 43. Genetics of Craniofacial and Wednesday, November 7 Musculoskeletal Disorders Room 124 #214–#222 10:30am–12:45 pm: Concurrent Platform Session A (11–19): 44. Tools for Phenotype Analysis Room 132 #223–#231 11. Genetics of Autism Spectrum 45. Therapy of Genetic Disorders Room 130 #232–#240 Disorders Hall D #7–#15 46. Pharmacogenetics: From Discovery 12. New Methods for Big Data Ballroom 103 #16–#24 to Implementation Room 123 #241–#249 13. Cancer Genetics I: Rare Variants Room 135 #25–#33 14. Quantitation and Measurement of Friday, November 9 Regulatory Oversight by the Cell Room 134 #34–#42 8:00am–10:15am: Concurrent Platform Session D (47–55): 15. New Loci for Obesity, Diabetes, and 47. Structural and Regulatory Genomic Related Traits Ballroom 104 #43–#51 Variation Hall D #250–#258 16. Neuromuscular Disease and 48. Neuropsychiatric Disorders Ballroom 103 #259–#267 Deafness Room 124 #52–#60 49. Common Variants, Rare Variants, 17. Chromosomes and Disease Room 132 #61–#69 and Everything in-Between Room 135 #268–#276 18. Prenatal and Perinatal Genetics Room 130 #70–#78 50. Population Genetics Genome-Wide Room 134 #277–#285 19. Vascular and Congenital Heart 51. Endless Forms Most Beautiful: Disease Room 123 #79–#87 Variant Discovery in Genomic Data Ballroom 104 #286–#294 52.
    [Show full text]
  • Alterations of Genetic Variants and Transcriptomic Features of Response to Tamoxifen in the Breast Cancer Cell Line
    Alterations of Genetic Variants and Transcriptomic Features of Response to Tamoxifen in the Breast Cancer Cell Line Mahnaz Nezamivand-Chegini Shiraz University Hamed Kharrati-Koopaee Shiraz University https://orcid.org/0000-0003-2345-6919 seyed taghi Heydari ( [email protected] ) Shiraz University of Medical Sciences https://orcid.org/0000-0001-7711-1137 Hasan Giahi Shiraz University Ali Dehshahri Shiraz University of Medical Sciences Mehdi Dianatpour Shiraz University of Medical Sciences Kamran Bagheri Lankarani Shiraz University of Medical Sciences Research Keywords: Tamoxifen, breast cancer, genetic variants, RNA-seq. Posted Date: August 17th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-783422/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/33 Abstract Background Breast cancer is one of the most important causes of mortality in the world, and Tamoxifen therapy is known as a medication strategy for estrogen receptor-positive breast cancer. In current study, two hypotheses of Tamoxifen consumption in breast cancer cell line (MCF7) were investigated. First, the effect of Tamoxifen on genes expression prole at transcriptome level was evaluated between the control and treated samples. Second, due to the fact that Tamoxifen is known as a mutagenic factor, there may be an association between the alterations of genetic variants and Tamoxifen treatment, which can impact on the drug response. Methods In current study, the whole-transcriptome (RNA-seq) dataset of four investigations (19 samples) were derived from European Bioinformatics Institute (EBI). At transcriptome level, the effect of Tamoxifen was investigated on gene expression prole between control and treatment samples.
    [Show full text]
  • Eif2b Is a Decameric Guanine Nucleotide Exchange Factor with a G2e2 Tetrameric Core
    ARTICLE Received 19 Feb 2014 | Accepted 15 Apr 2014 | Published 23 May 2014 DOI: 10.1038/ncomms4902 OPEN eIF2B is a decameric guanine nucleotide exchange factor with a g2e2 tetrameric core Yuliya Gordiyenko1,2,*, Carla Schmidt1,*, Martin D. Jennings3, Dijana Matak-Vinkovic4, Graham D. Pavitt3 & Carol V. Robinson1 eIF2B facilitates and controls protein synthesis in eukaryotes by mediating guanine nucleotide exchange on its partner eIF2. We combined mass spectrometry (MS) with chemical cross- linking, surface accessibility measurements and homology modelling to define subunit stoichiometry and interactions within eIF2B and eIF2. Although it is generally accepted that eIF2B is a pentamer of five non-identical subunits (a–e), here we show that eIF2B is a decamer. MS and cross-linking of eIF2B complexes allows us to propose a model for the subunit arrangements within eIF2B where the subunit assembly occurs through catalytic g- and e-subunits, with regulatory subunits arranged in asymmetric trimers associated with the core. Cross-links between eIF2 and eIF2B allow modelling of interactions that contribute to nucleotide exchange and its control by eIF2 phosphorylation. Finally, we identify that GTP binds to eIF2Bg, prompting us to propose a multi-step mechanism for nucleotide exchange. 1 Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, UK. 2 MRC Laboratory of Molecular Biology, University of Cambridge, Francis Crick Avenue, Cambridge CB2 0QH, UK. 3 Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK. 4 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
    [Show full text]
  • Original Article URI1 Amplification in Uterine Carcinosarcoma Associates with Chemo-Resistance and Poor Prognosis
    Am J Cancer Res 2015;5(7):2320-2329 www.ajcr.us /ISSN:2156-6976/ajcr0010111 Original Article URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis Yu Wang1,2, Michael J Garabedian2, Susan K Logan1,3 Departments of 1Urology, 2Microbiology, 3Biochemistry and Molecular Pharmacology, New York University School of Medicine, 550 First Avenue, MSB235, New York, NY 10016, USA Received May 11, 2015; Accepted June 11, 2015; Epub June 15, 2015; Published July 1, 2015 Abstract: Uterine carcinosarcoma (UCS) is a rare type of cancer and accounts for 5% of uterine malignancies. However, UCS patients suffer a high prevalence of chemo-resistance and a very poor prognosis compared to uterine cancer patients. URI is a chaperone with functions in transcription. We analyzed the somatic URI1 copy number variation in 57 post-menopausal non-metastatic UCS patients in comparison to 363 uterine corpus endometrial carcinomas. URI1 amplification was detected in 40% (23/57) of primary UCS and 5.5% (20/363) of uterine carci- nomas. UCS patients with URI1 amplification exhibited 13% (3/23) tumor-free survival compared to 41% (14/34) in the absence of URI amplification (P=0.023).URI1 amplification (OR=6.54, P=0.027), weight (OR=1.068, P=0.024), hypertension (OR=3.35, P=0.044), and tumor stage (OR=2.358, P=0.018) associated with poor survival. Patients treated with hormone replacement therapy (OR=15.87, P=0.011) displayed enhanced overall survival. Combined radiation and chemotherapy improved patient survival (median survival=2043 days) compared to single (median survival=597 days) or no treatment (median survival=317 days, P=0.0016).
    [Show full text]
  • Cofactor Dependent Conformational Switching of Gtpases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 1704 Biophysical Journal Volume 95 August 2008 1704–1715 Cofactor Dependent Conformational Switching of GTPases Vasili Hauryliuk,*y Sebastian Hansson,z and Ma˚ns Ehrenberg* *Department of Cell and Molecular Biology, Molecular Biology Program, Uppsala University, Uppsala, Sweden; yEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; and zLaboratoire d’Enzymologie et Biochimie Structurales, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France ABSTRACT This theoretical work covers structural and biochemical aspects of nucleotide binding and GDP/GTP exchange of GTP hydrolases belonging to the family of small GTPases. Current models of GDP/GTP exchange regulation are often based on two specific assumptions. The first is that the conformation of a GTPase is switched by the exchange of the bound nucleotide from GDP to GTP or vice versa. The second is that GDP/GTP exchange is regulated by a guanine nucleotide exchange factor, which stabilizes a GTPase conformation with low nucleotide affinity. Since, however, recent biochemical and structural data seem to contradict this view, we present a generalized scheme for GTPase action. This novel ansatz accounts for those important cases when conformational switching in addition to guanine nucleotide exchange requires the presence of cofactors, and gives a more nuanced picture of how the nucleotide exchange is regulated. The scheme is also used to discuss some problems of interpretation that may arise when guanine nucleotide exchange mechanisms are inferred from experiments with analogs of GTP, like GDPNP, GDPCP, and GDP g S.
    [Show full text]
  • 1 Introduction + 1.1 Ruvbl1 and Ruvbl2 Are Highly Conserved AAA Proteins
    1. Introduction 1 Introduction + 1.1 RuvBL1 and RuvBL2 are highly conserved AAA proteins RuvBL1 and its homolog RuvBL2 are ubiquitously expressed proteins (Bauer et al. 1998) that belong to the AAA+ family of ATPases (ATPases associated with diverse cellular activities) (Neuwald et al. 1999). This class of ATPases includes nucleic acid processing enzymes, chaperones and proteases. AAA+ proteins often form hexameric ring structures and contain conserved motifs for ATP binding and hydrolysis like the Walker A (GXXXXGKT) and Walker B box (DEXH/N) (Walker et al. 1982), the Arg-finger and sensor residues. All AAA+ proteins use ATP binding and hydrolysis to exert mechanical forces. ATP hydrolysis is clearly essential for the biological activity of RuvBL1 and RuvBL2 (Feng et al. 2003; Jonsson et al. 2004; Wood et al. 2000). RuvBL1 and RuvBL2, consisting of 456 and 463 amino acids respectively, are mainly localised in the nucleus, but also found in the cytosol (Holzmann et al. 1998; Kim et al. 2006; Lim et al. 2000; Salzer et al. 1999). RuvBL2 exhibits 43 % sequence identity and 65 % sequence similarity to RuvBL1. These proteins were originally identified by several unrelated approaches and are therefore known under diverse names (see Table 1). RuvBL1 RuvBL2 Explanation Reference TIP49 TIP48 TATA-binding protein (TBP)-interacting protein (Makino et al. 1998; Wood et al. 2000) TIP49a TIP49b TBP-interacting protein (Kanemaki et al. 1999) Pontin52 Reptin52 repressing Pontin52 (Bauer et al. 2000; Bauer et al. 1998) TAP54α TAP54β TIP60-associated protein (Ikura et al. 2000) TIH1 TIH2 TIP49a/b homolog (Lim et al. 2000) ECP54 ECP51 erythrocyte cytosolic protein (Salzer et al.
    [Show full text]
  • A Dissertation Entitled Characterization of the CXCR4
    A Dissertation entitled Characterization of the CXCR4-LASP1-eIF4F Axis in Triple-Negative Breast Cancer by Cory M Howard Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biomedical Sciences ___________________________________________ Dayanidhi Raman, B.V.Sc., Ph.D., Committee Chair ___________________________________________ Amit Tiwari, Ph.D., Committee Member ___________________________________________ Ritu Chakravarti, Ph.D., Committee Member ___________________________________________ Nagalakshmi Nadiminty, Ph.D., Committee Member ___________________________________________ Saori Furuta, Ph.D., Committee Member ___________________________________________ Shi-He Liu, M.D., Committee Member ___________________________________________ Amanda C. Bryant-Friedrich, Ph.D., Dean College of Graduate Studies The University of Toledo August 2020 © 2020 Cory M. Howard This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Characterization of the CXCR4-LASP1-eIF4F Axis in Triple-Negative Breast Cancer by Cory M. Howard Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biomedical Sciences The University of Toledo August 2020 Triple-negative breast cancer (TNBC) remains clinically challenging as effective targeted therapies are still lacking. In addition, patient mortality mainly results from the metastasized
    [Show full text]
  • Chapter 2 Gene Regulation and Speciation in House Mice
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Gene regulation and the genomic basis of speciation and adaptation in house mice (Mus musculus) Permalink https://escholarship.org/uc/item/8ck133qd Author Mack, Katya L Publication Date 2018 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Gene regulation and the genomic basis of speciation and adaptation in house mice (Mus musculus) By Katya L. Mack A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Integrative Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Michael W. Nachman, Chair Professor Rasmus Nielsen Professor Craig T. Miller Fall 2018 Abstract Gene regulation and the genomic basis of speciation and adaptation in house mice (Mus musculus) by Katya Mack Doctor of Philosophy in Integrative Biology University of California, Berkeley Professor Michael W. Nachman, Chair Gene expression is a molecular phenotype that is essential to organismal form and fitness. However, how gene regulation evolves over evolutionary time and contributes to phenotypic differences within and between species is still not well understood. In my dissertation, I examined the role of gene regulation in adaptation and speciation in house mice (Mus musculus). In chapter 1, I reviewed theoretical models and empirical data on the role of gene regulation in the origin of new species. I discuss how regulatory divergence between species can result in hybrid dysfunction and point to areas that could benefit from future research. In chapter 2, I characterized regulatory divergence between M.
    [Show full text]
  • Gene Regulation Underlies Environmental Adaptation in House Mice
    Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Research Gene regulation underlies environmental adaptation in house mice Katya L. Mack,1 Mallory A. Ballinger,1 Megan Phifer-Rixey,2 and Michael W. Nachman1 1Department of Integrative Biology and Museum of Vertebrate Zoology, University of California, Berkeley, California 94720, USA; 2Department of Biology, Monmouth University, West Long Branch, New Jersey 07764, USA Changes in cis-regulatory regions are thought to play a major role in the genetic basis of adaptation. However, few studies have linked cis-regulatory variation with adaptation in natural populations. Here, using a combination of exome and RNA- seq data, we performed expression quantitative trait locus (eQTL) mapping and allele-specific expression analyses to study the genetic architecture of regulatory variation in wild house mice (Mus musculus domesticus) using individuals from five pop- ulations collected along a latitudinal cline in eastern North America. Mice in this transect showed clinal patterns of variation in several traits, including body mass. Mice were larger in more northern latitudes, in accordance with Bergmann’s rule. We identified 17 genes where cis-eQTLs were clinal outliers and for which expression level was correlated with latitude. Among these clinal outliers, we identified two genes (Adam17 and Bcat2) with cis-eQTLs that were associated with adaptive body mass variation and for which expression is correlated with body mass both within and between populations. Finally, we per- formed a weighted gene co-expression network analysis (WGCNA) to identify expression modules associated with measures of body size variation in these mice.
    [Show full text]
  • Convergent Regulatory Evolution and Loss of Flight in Paleognathous Birds
    Convergent regulatory evolution and loss of flight in paleognathous birds The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Sackton, Timothy B., Phil Grayson, Alison Cloutier, Zhirui Hu, Jun S. Liu, Nicole E. Wheeler, Paul P. Gardner, et al. 2019. Convergent Regulatory Evolution and Loss of Flight in Paleognathous Birds. Science 364 (6435): 74–78. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:39865637 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#OAP Convergent regulatory evolution and loss of flight in palaeognathous birds Timothy B. Sackton* (1,2), Phil Grayson (2,3), Alison Cloutier (2,3), Zhirui Hu (4), Jun S. Liu (4), Nicole E. Wheeler (5,6), Paul P. Gardner (5,7), Julia A. Clarke (8), Allan J. Baker (9,10), Michele Clamp (1), Scott V. Edwards* (2,3) Affiliations: 1) Informatics Group, Harvard University, Cambridge, USA 2) Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, USA 3) Museum of Comparative Zoology, Harvard University, Cambridge, USA 4) Department of Statistics, Harvard University, Cambridge, USA 5) School of Biological Sciences, University of Canterbury, New Zealand 6) Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK 7) Department of Biochemistry, University of Otago, New Zealand 8) Jackson School of Geosciences, The University of Texas at Austin, Austin, USA 9) Department of Natural History, Royal Ontario Museum, Toronto, Canada 10) Department of Ecology and Evolutionary Biology, University of Toronto, Toronto, Canada *correspondence to: TBS ([email protected]) or SVE ([email protected]) 1 Whether convergent phenotypic evolution is driven by convergent molecular changes, in proteins or regulatory regions, are core questions in evolutionary biology.
    [Show full text]
  • Nck Adapter Proteins: Functional Versatility in T Cells Marcus Lettau, Jennifer Pieper and Ottmar Janssen
    Cell Communication and Signaling BioMed Central Review Open Access Nck adapter proteins: functional versatility in T cells Marcus Lettau, Jennifer Pieper and Ottmar Janssen Address: 1University Hospital Schleswig-Holstein Campus Kiel, Institute of Immunology, Molecular Immunology, Arnold-Heller-Str 3, Bldg 17, D-24105 Kiel, Germany E-mail: Marcus Lettau* - [email protected]; Jennifer Pieper - [email protected]; Ottmar Janssen - [email protected] *Corresponding author Published: 02 February 2009 Received: 2 December 2008 Cell Communication and Signaling 2009, 7:1 doi: 10.1186/1478-811X-7-1 Accepted: 2 February 2009 This article is available from: http://www.biosignaling.com/content/7/1/1 © 2009 Lettau et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Nck is a ubiquitously expressed adapter protein that is almost exclusively built of one SH2 domain and three SH3 domains. The two isoproteins of Nck are functionally redundant in many aspects and differ in only few amino acids that are mostly located in the linker regions between the interaction modules. Nck proteins connect receptor and non-receptor tyrosine kinases to the machinery of actin reorganisation. Thereby, Nck regulates activation-dependent processes during cell polarisation and migration and plays a crucial role in the signal transduction of a variety of receptors including for instance PDGF-, HGF-, VEGF- and Ephrin receptors. In most cases, the SH2 domain mediates binding to the phosphorylated receptor or associated phosphoproteins, while SH3domaininteractionsleadtotheformationoflargerproteincomplexes.InTlymphocytes,Nck plays a pivotal role in the T cell receptor (TCR)-induced reorganisation of the actin cytoskeleton and the formation of the immunological synapse.
    [Show full text]
  • Buy Viagra Brand
    A Canonical Cancer-Network Map Eugene F. Douglass Jr., Ph.D. ;<=:>&'? Cell-Surface Interactions @@@JJ; Growth Receptor Signalling Cell-ECM Growth/Motility Proliferation Cell-Cell Contact Inhibition Metabolism MMP COLONIC CRYPT IGF/IGFR-1 EGFR / ErbB WNT ! WNT ! WNT WNT Integrin WNT RAS must be held near PI3K to activate it 5 CAD-domains Signalosome R-spdn p.195 GTP RAS PTEN NF1 SOS PLC PIP3 E-cadherin SHC PIP RASGAP GRB2 2 ZNRF3 p120 p120 " p120 p120 p120 p120 FZD Akt PDK1 PH JM Src-dep Y845 STAT3 GDP GTP Y974 F-actin PI3K PTB SHC/SHP2 GRB2 LRP Assembly vincilin talin PI3K Integrin-Linked Kinase(ILK) Y981 RAS RAS LGR RNF43 NCK2 ! ! ! ARP2/3 FAK Y988 FAK 2 min PINCH SOCS3 C hevell Akt KD s e paxilin SOS i d PDK1 Src IRS1 ! ! ! d paxilin Src (PKB) internlz AP2 RSU1 Y1015 ½ HIC5 ! t PI3K Y460 SOCS1/6 Y992 PLC" Parvin Src TESK1 PI3K Y546 SHIP2 GTP p130Cas CRK CSG ubiq axin PAK1 Y1091 Y1045 CBL S46-7 RAF-1 KSR DOCK180 SOS PI3K Y608 S1057 = GSK3 PI3K Y628 Y1127 Y1068 GRB2 14-3-3 14-3-3 PI3K Y658 GRB2 Y1086 B-RAF C-RAF GSK RHEB PI3K Y690 RASGAP 9 Wtx mTOR1 Y1163 Y1101 Gab1 Apc PI3K Y727 Y1167 PI3K Y759 RASGAP Y1168 MAPK Rac GTP Y1148 SHC GRB2 p120 p120 Y815 SHIP2 RhoGEF RalGEF p70-S6K Y1215 ! ! Y1175 SOS GTP Y891 phos SHP1 Cdc42 Y903 SHIP2 Y1253 SHP2 GRB2 ! ! PTP1 MKK1/2 PI3K Y935 Wtx GTP CT ! Rho PI3K Y983 SHIP2 Y1282 GRB2 SHP2 Y1006 Y1283 RalBP1 RalA/B GTP MP1 axin PI3K Y1352 PI3K Erk1/2 GSK3 Sprouty Apc MKP1 GTP GRB2 SHP2 Y1173 Rac 1.
    [Show full text]